Literature DB >> 11054280

Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes.

T Matsumura1, A Ito, T Takii, H Hayashi, K Onozaki.   

Abstract

Toll-like receptor (TLR) 2 and TLR4 are members of the interleukin-1 receptor (IL-1R) family and transduce similar signals as IL-1R in response to bacteria and bacterial components. In this study, we investigated the regulation of their gene expression in murine tissues, especially in the liver and hepatocytes. When mice were administered lipopolysaccharide (LPS), TLR2 mRNA was upregulated in the brain, heart, lung, liver, and kidney. In contrast, it was downregulated in the spleen. TLR4 mRNA was decreased in the brain. In the heart and lung, it increased, and it was not affected in the liver, kidney, and spleen. TLR mRNA was further analyzed in the liver and hepatocytes. Like LPS treatment, administration of IL-1, IL-6, or tumor necrosis factor (TNF) upregulated TLR2 mRNA. However, none of them affected the TLR4 mRNA level. In primary cultured hepatocytes, TLR2 mRNA was upregulated by LPS, IL-1, or TNF but not by IL-6 or dexamethasone. None of them affected TLR4 mRNA expression. Similar responses were observed in the murine hepatoma cell line Hepa 1-6. These results suggest that in infection with gram-negative bacteria, LPS and proinflammatory cytokines differentially regulate gene expression of TLR2 and TLR4 in murine hepatocytes, which may lead to pathologic and host defense reactions in the liver.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054280     DOI: 10.1089/10799900050163299

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  58 in total

Review 1.  Hepatocytes as Immunological Agents.

Authors:  Ian N Crispe
Journal:  J Immunol       Date:  2016-01-01       Impact factor: 5.422

2.  Native macrophages genetically modified to express heme oxygenase 1 protect rat liver transplants from ischemia/reperfusion injury.

Authors:  Xiu-Da Shen; Bibo Ke; Yoichiro Uchida; Haofeng Ji; Feng Gao; Yuan Zhai; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

3.  Cell type-specific expression and function of toll-like receptors 2 and 4 in human placenta: implications in fetal infection.

Authors:  Y Ma; G Krikun; V M Abrahams; G Mor; S Guller
Journal:  Placenta       Date:  2007-06-22       Impact factor: 3.481

4.  Damage-associated molecular patterns (DAMPs) released after burn are associated with inflammation and monocyte activation.

Authors:  Meenakshi Rani; Susannah E Nicholson; Qiong Zhang; Martin G Schwacha
Journal:  Burns       Date:  2016-10-27       Impact factor: 2.744

Review 5.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

6.  NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis.

Authors:  Shin Maeda
Journal:  Gastroenterol Res Pract       Date:  2010-11-28       Impact factor: 2.260

7.  TLR2 mRNA upregulation in ischemic lobes in mouse partial hepatic ischemia/reperfusion injury model.

Authors:  Jinxiang Zhang; Heshui Wu; Lin Wang; Jinhui Zhang; Hui Wang; Qichang Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

8.  Effect of JIANPI HUOXUE decoction on inflammatory cytokine secretion pathway in rat liver with lipopolysaccharide challenge.

Authors:  Jing-Hua Peng; Yi-Yang Hu; Yang Cheng; Chong Han; Li-Li Xu; Qin Feng; Shao-Dong Chen; Qing Tao; Hong-Shan Li; Xue-Mei Li
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

9.  Toll-like receptors as targets in chronic liver diseases.

Authors:  A Mencin; J Kluwe; R F Schwabe
Journal:  Gut       Date:  2009-05       Impact factor: 23.059

Review 10.  Endotoxin and cancer.

Authors:  Jessica I Lundin; Harvey Checkoway
Journal:  Environ Health Perspect       Date:  2009-05-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.